If you're on the lookout for ASX 200 shares to add to your portfolio, then the two listed below could be worth a closer look.
Here's what you need to know about these shares right now:
Altium Limited (ASX: ALU)
The first ASX 200 share that could be in the buy zone is Altium. It is an electronic design software provider that is best-known for its Altium Designer and Altium 365 platforms. These platforms are regarded as the best in the industry and are used by many of the world's largest companies for electronic/printed circuit board design. Among its growing user base are the likes of BAE Systems, Microsoft, and Tesla.
In addition, the company has a parts search engine called Octopart that is performing exceptionally well thanks to supply chain disruption. All in all, the company appears well-placed for growth over the next decade. Particularly given the booming internet of things and artificial intelligence markets. These are driving strong demand for electronic design software.
Bell Potter currently has a buy rating and $34.00 price target on Altium's shares.
CSL Limited (ASX: CSL)
Another ASX 200 share that could be a buy for investors this month is CSL. It is one of the world's leading biotechnology companies, comprising the CSL Behring and Seqirus businesses. These businesses are leaders in their respective fields – plasma therapies and vaccines.
And while plasma collection headwinds have been weighing on sentiment in 2022, industry data appears to show that collections have finally returned to pre-COVID levels. Combined with the impending blockbuster acquisition of Vifor Pharma and its huge annual investment in research and development, the future looks bright for CSL.
Citi currently has a buy rating and $330.00 price target on the company's shares.
